TM9SF2 Antibody (Rabbit mAb) [L17H20]

CatNo: F6422

    Application: Reactivity:

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:2000
    1:150
    Application
    WB, IHC, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    76 kDa 55 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    TM9SF2 Antibody (Rabbit mAb) [L17H20] detects endogenous levels of total TM9SF2 protein.
    Clone
    L17H20
    Synonym(s)
    Transmembrane 9 superfamily member 2, p76, TM9SF2
    Background
    TM9SF2, or transmembrane 9 superfamily member 2, is a conserved nonaspanin family membrane protein characterized by nine predicted transmembrane segments and predominant localization to endosomal and Golgi-associated intracellular compartments, where it functions as a channel or small-molecule transporter that influences vesicle physiology and trafficking fidelity. TM9SF2 colocalizes with transferrin receptors and subsets of mannose 6‑phosphate receptors in endosomes rather than at the plasma membrane or classical Golgi cisternae, a distribution that aligns with its contribution to endosomal ion homeostasis and luminal pH regulation, thereby affecting cargo sorting and receptor recycling. TM9SF2 is part of a broader TM9SF network that modulates phagocytic uptake and actin cytoskeleton control and interacts with pattern-recognition receptors such as PGRP‑LC, suggesting roles in innate immune receptor positioning and in preventing inappropriate signaling from unstimulated receptors. In human colorectal cancer, approximately one third of patient tumors show elevated TM9SF2 mRNA, and loss of TM9SF2 reduces anchorage-independent growth and diminishes tumor fitness in vitro and in vivo, implicating this transporter-like protein as a positive regulator of malignant proliferation and survival. Transcriptome profiling of TM9SF2‑deficient colorectal cancer cells reveals altered expression of genes linked to cell-cycle progression, oxidative phosphorylation and ceramide signaling, pointing to a role for TM9SF2 in coupling endosomal/Golgi function to metabolic and stress pathways that support tumor growth. TM9SF2 is required for maintaining proper glycosylation in the Golgi: knockout cells exhibit reduced levels of glycosphingolipids such as globotriaosylceramide (Gb3) and display defective endosomal trafficking, indicating that TM9SF2 activity supports glycan synthesis and vesicular transport circuits that underlie membrane composition and receptor routing. These trafficking and glycosylation roles are relevant for host–pathogen interactions and toxin responses, as TM9SF2 has emerged as a host factor for multiple lethal pathogens and for ricin-induced cytotoxicity, where its contribution to Golgi integrity and endosomal transport influences toxin routing and cellular susceptibility.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください